Literature DB >> 2469232

Liver transplantation: an unfinished product.

T E Starzl1, S Todo, A G Tzakis, R D Gordon, L Makowka, A Stieber, L Podesta, K Yanaga, W Concepcion, S Iwatsuki.   

Abstract

Liver transplantation has become an extraordinarily valuable and useful operation, but one that is not perfect and that has not been exploited to anything like its full potential. Better immunosuppression may become available soon as exemplified by developments with the Japanese drug, FK506. Improved preservation with the UW solution is already here. With these advantages, liver transplantation is certain to become far more widely used than at any time in the past. Examples were cited of innovative approaches using liver transplantation for the treatment of hepatic malignancies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2469232      PMCID: PMC2950325     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  13 in total

1.  Homotransplantation of multiple visceral organs.

Authors:  T E STARZL; H A KAUPP; D R BROCK; G W BUTZ; J W LINMAN
Journal:  Am J Surg       Date:  1962-02       Impact factor: 2.565

2.  The isolated perfused rabbit liver as a model for assessment of organ preservation.

Authors:  N V Jamieson; R Sundberg; S Lindell; J H Southard; F O Belzer
Journal:  Transplant Proc       Date:  1988-10       Impact factor: 1.066

3.  Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat.

Authors:  T Ochiai; K Nakajima; M Nagata; T Suzuki; T Asano; T Uematsu; T Goto; S Hori; T Kenmochi; T Nakagoori
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

4.  Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report.

Authors:  S Iwatsuki; T E Starzl; S Todo; R D Gordon; C O Esquivel; A G Tzakis; L Makowka; J W Marsh; B Koneru; A Stieber
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

5.  The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation.

Authors:  T E Starzl; T L Marchioro; K A Porter; Y Iwasaki; G J Cerilli
Journal:  Surg Gynecol Obstet       Date:  1967-02

Review 6.  Evolution of liver transplantation.

Authors:  T E Starzl; S Iwatsuki; D H Van Thiel; J C Gartner; B J Zitelli; J J Malatack; R R Schade; B W Shaw; T R Hakala; J T Rosenthal; K A Porter
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

7.  Simple hypothermic preservation for transporting human livers long distances for transplantation. Report of 12 cases.

Authors:  W J Wall; R Y Calne; B M Herbertson; P G Baker; D P Smith; J Underwood; A Kostakis; R Williams
Journal:  Transplantation       Date:  1977-03       Impact factor: 4.939

8.  Human X (mouse X human) hybridomas stably producing human antibodies.

Authors:  L Ostberg; E Pursch
Journal:  Hybridoma       Date:  1983

9.  Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction.

Authors:  S Todo; Y Ueda; J A Demetris; O Imventarza; M Nalesnik; R Venkataramanan; L Makowka; T E Starzl
Journal:  Surgery       Date:  1988-08       Impact factor: 3.982

10.  Studies in small bowel transplantation. Prevention of graft-versus-host disease with preservation of allograft function by donor pretreatment with antilymphocyte serum.

Authors:  D Shaffer; T Maki; S J DeMichele; M D Karlstad; B R Bistrian; K Balogh; A P Monaco
Journal:  Transplantation       Date:  1988-02       Impact factor: 4.939

View more
  13 in total

1.  HLA matching effect in liver transplantation.

Authors:  A Yagihashi; M Kobayashi; K Noguchi; A Konno; Y Yoshida; K Terasawa; T E Starzl; Y Iwaki
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

2.  Comparison of UW with other solutions for liver preservation in dogs.

Authors:  S Todo; L Podesta; Y Ueda; O Imventarza; A Casavilla; A Oks; K Okuda; M Nalesnik; R Venkataramanan; T E Starzl
Journal:  Clin Transplant       Date:  1989-10       Impact factor: 2.863

Review 3.  New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.

Authors:  L Hammarström; C I Smith
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

4.  Transplantation.

Authors:  T E Starzl
Journal:  JAMA       Date:  1989-05-19       Impact factor: 56.272

5.  Liver retransplantation in adults: overall results and determinant factors affecting the outcome.

Authors:  P Morel; H L Rilo; A G Tzakis; S Todo; R D Gordon; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

6.  A new liver perfusion and preservation system for transplantation research in large animals.

Authors:  K Yanaga; L Makowka; G Lebeau; R R Hwang; M Shimada; S Kakizoe; A J Demetris; T E Starzl
Journal:  J Invest Surg       Date:  1990       Impact factor: 2.533

7.  Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease.

Authors:  S Todo; A J Demetris; D Van Thiel; L Teperman; J J Fung; T E Starzl
Journal:  Hepatology       Date:  1991-04       Impact factor: 17.425

8.  Total hepatectomy and liver transplantation as two-stage procedure.

Authors:  B Ringe; N Lübbe; E Kuse; U Frei; R Pichlmayr
Journal:  Ann Surg       Date:  1993-07       Impact factor: 12.969

Review 9.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

10.  Liver transplantation in Taiwan: the Chang Gung experience.

Authors:  C L Chen; K L Wang; Y L Hui; W B Shieh
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.